Bridgeway Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Bridgeway Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+20,000	New	+$258K	﹤0.01%	1007
2022 Q3	–	Sell	-2	Closed	-$48K	–	1453
2022 Q2	$48K	Buy	+2	New	+$148K	﹤0.01%	1283
2022 Q1	–	Hold	0	–	–	–	1306
2021 Q4	–	Hold	0	–	–	–	1258
2021 Q3	–	Hold	0	–	–	–	1281
2021 Q2	–	Hold	0	–	–	–	1242
2021 Q1	–	Hold	0	–	–	–	1202
2020 Q4	–	Hold	0	–	–	–	1222
2020 Q3	–	Hold	0	–	–	–	1159
2020 Q2	–	Hold	0	–	–	–	1179
2016 Q4	–	Hold	0	–	-$66K	–	1465
2016 Q3	–	Hold	0	–	–	–	1392
2016 Q2	–	Hold	0	–	–	–	1316
2016 Q1	–	Hold	0	–	–	–	1280
2015 Q4	–	Hold	0	–	–	–	904
2015 Q3	–	Hold	0	–	–	–	1029
2015 Q2	–	Hold	0	–	–	–	1005

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bridgeway Capital Management's TNXP Position: Q2 2026 in Review

Bridgeway Capital Management opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 20,000 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #1007 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in TNXP as recently as Q2 2022.

Bridgeway Capital Management first reported a position in TNXP in Q2 2022 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Bridgeway Capital Management held 20,000 shares of Tonix Pharmaceuticals worth $255K as of Q2 2026.
Tonix Pharmaceuticals was a new Bridgeway Capital Management position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1007 holding.
Bridgeway Capital Management first reported a position in Tonix Pharmaceuticals in Q2 2022 and has held it in 2 quarters since.
103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.